Cortez MA et al.
Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer (2019) 58:244-253. Related Pathway
Zhou S et al.
Chronic Platelet-derived Growth Factor Receptor signaling exerts control over initiation of protein translation in glioma. Life Sci Alliance (2018) 1:e201800029. Related Pathway
Jun HJ et al.
A PDGFRalpha-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine. Nat Commun (2018) 9:3116. Related Pathway
Gharpure KM et al.
FABP4 as a key determinant of metastatic potential of ovarian cancer. Nat Commun (2018) 9:2923. Related Pathway
Koupenova M et al.
Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res (2018) 122:337-351. Related Pathway
Hulsmans M et al.
Cardiac macrophages promote diastolic dysfunction. J Exp Med (2018) 215:423-440. Related Pathway
Leung CS et al.
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance. J Clin Invest (2018) 128:589-606. Related Pathway
Vannini I et al.
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun (2017) 8:1801. Related Pathway
Bei Y et al.
Extracellular vesicles in cardiovascular theranostics. Theranostics (2017) 7:4168-4182. Review Biomarkers Related Pathway
Mitamura T et al.
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP). Oncogene (2018) 37:722-731. Related Pathway
Shen P et al.
To Wnt or lose: The missing non-coding linc in colorectal cancer. Int J Mol Sci (2017) 18:9. Related Pathway
Datta A et al.
Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells. Cancer Lett (2017) 408:73-81. exRNA and EV Biology EV Biology Related Pathway
Klingenberg M et al.
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. J Hepatol (2017) 67:603-618. Review Biomarkers Related Pathways: 1, 2
Giza DE et al.
Cellular and viral microRNAs in sepsis: Mechanisms of action and clinical applications. Cell Death Differ (2016) 23:1906-1918. Related Pathway
Ciccone M & Calin GA.
MicroRNAs in chronic lymphocytic leukemia: An old disease with new genetic insights. MicroRNA (2016) 5:106-112. Related Pathway
Parasramka MA et al.
Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacol Ther (2016) 161:67-78. Review Therapeutics Related Pathway
Shields BB et al.
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression. Mol Syst Biol (2015) 11:842. exRNA Biology Therapeutics Related Pathways: 1, 2
Wong HK et al.
The Cancer Genome Atlas analysis predicts microRNA for targeting cancer growth and vascularization in glioblastoma. Mol Ther (2015) 23:1234-47. Related Pathway
Li K et al.
Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-kappaB-driven inflammation and atherosclerosis. Circ Res (2015) 117:e1-e11. Related Pathway
Miyake TM et al.
XPO1/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5A. Clin Cancer Res (2015) 21:3286-97. Related Pathway
Liu X et al.
miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab (2015) 21:584-95. Related Pathway
Gonzalez-Villasana V et al.
Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer. Clin Cancer Res (2015) 21:2127-37. Therapeutics Related Pathway
Danielson KM & Das S.
Extracellular vesicles in heart disease: Excitement for the future? Exosomes Microvesicles (2014) 2:1. Review exRNA and EV Biology EV Biology Related Pathway
van den Beucken T et al.
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat Commun (2014) 5:5203. Related Pathway
Gangoda L et al.
Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic? Proteomics (2015) 15:260-71. Review exRNA and EV Biology EV Biology Related Pathway
Leung CS et al.
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. Nat Commun (2014) 5:5092. Related Pathway
Han C et al.
The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression. Cell Rep (2014) 8:1447-60. Related Pathway
Krzeszinski JY et al.
MiR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature (2014) 512:431-5. Highly Cited (300+) exRNA Biology Therapeutics Related Pathway
Thomas MF, L’Etoile ND & Ansel KM.
Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways. Trends Genet (2014) 30:298-307. Review exRNA and EV Biology Related Pathway
Yang L et al.
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol Syst Biol (2014) 10:728. Related Pathway
Hu W et al.
Notch3 pathway alterations in ovarian cancer. Cancer Res (2014) 74:3282-93. Related Pathway
Takahashi K et al.
Long noncoding RNA in liver diseases. Hepatology (2014) 60:744-53. Review exRNA and EV Biology exRNA Biology Related Pathway
Beaulieu LM et al.
Interleukin 1 receptor 1 and interleukin 1beta regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol (2014) 34:552-64. Related Pathway
Ozpolat B, Sood AK & Lopez-Berestein G.
Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Deliv Rev (2014) 66:110-6. Highly Cited (250+) Therapeutics Related Pathway